Edward Wancewicz
14Patents
6h-index
12Co-inventors
59Inventor score
Filing activity: May 16, 2000 → Apr 28, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8143230B2 | Compounds and methods for modulating expression of PCSK9 | Chemistry; Metallurgy | 42 | Active |
| US9045754B2 | Short antisense compounds with gapmer configuration | Chemistry; Metallurgy | 41 | Active |
| US9617540B2 | Compounds and methods for modulating gene expression | Chemistry; Metallurgy | 24 | Active |
| US8188059B2 | Compounds and methods for modulating expression of GCGR | Chemistry; Metallurgy | 22 | Active |
| US6331399A | Antisense inhibition of tert expression | Emerging Cross-Sectional Technologies | 14 | Expired |
| US8258105B2 | Antisense oligonucleotides optimized for kidney targeting | Chemistry; Metallurgy | 9 | Expired |
| US8586554B2 | Compounds and methods for modulating expression of PTP1B | Chemistry; Metallurgy | 6 | Active |
| US8372967B2 | Compounds and methods for modulating expression of GCCR | Chemistry; Metallurgy | 4 | Active |
| US6492171B2 | Antisense modulation of TERT expression | Emerging Cross-Sectional Technologies | 2 | Expired |
| US8673871B2 | Compounds and methods for modulating expression ApoB | Chemistry; Metallurgy | 2 | Active |
| US8362232B2 | Compounds and methods for modulating expression of SGLT2 | Chemistry; Metallurgy | 1 | Active |
| US6607915B1 | Antisense inhibition of E2A-Pbx1 expression | Emerging Cross-Sectional Technologies | 1 | Expired |
| US8084436B2 | Modulation of SGLT2 expression | Chemistry; Metallurgy | 1 | Active |
| US8969316B2 | Compounds and methods for modulating expression of DGAT2 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.